Recent news on Pletal-Cilostazol

UCB acquistion of Schwarz Pharma moves ever closer  -  Dec 12, 2006
Pharma Times (subscription),Meantime, Schwarz has announced an agreement with Otsuka Pharmaceutical of Japan to jointly market the latter's Pletal (cilostazol) for stage II peripheral

SCHWARZ PHARMA Announces Agreement With OTSUKA For Jointly ...  -  Dec 14, 2006
Medical News Today (press release),Pletal (cilostazol, developed by Otsuka) is an oral treatment drug for stage II peripheral arterial occlusive disease (intermittent claudication) that has

Business News  -  Dec 19, 2006
American Digital Networks (press release),Pletal (cilostazol) - launched January 1999 for the intermittent claudication associated with peripheral arterial disease.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional